Skip to main content

Blogs

5 Mistakes When Diagnosing Adult-Onset Still’s Disease

Adult-onset Still's posses a interestng and diagnostic challeng when encountered. Here are 5 tips to improve your diagnostic acumen for this febrile disorder.

Dress Syndrome – A Diagnostic and Management Nightmare

The DRESS syndrome is a rare and sometimes catastrophic disorder resulting from specific drug exposures, including allopurinol, minocycline, INH, anticonvulsants or retroviral agents.

The Best Kind of Arthritis

I was recently asked, “what is the best kind of arthritis to have?” My response is based on diagnosibility, treatability and safety of necessary treatment. 

The Evolution of Drug Safety

Drug efficacy is swiftly proven in phase II and III trials. Yet drug safety requires time, wider exposure, physician education and patient acceptance to be fully established.

How I Choose Biologics

Clinical decision-making, occurring at the intersection of the ’art’ and the ’science’ of medicine, remains enigmatic and controversial. 

Annual Review of Rheumatology Advances - 2014

This retrospective highlights several of the most impactful publications, trends, research and news that occurred in 2014.

Rheumatology Pearls from Twitter - Really?

To many of my colleagues (admitted Luddites) the mere mention of Twitter results in the “omi-god 360” eye roll with an accompanying snide comment.

A Rheumatology State of Mind

In 2012, a Medscape survey of US physicians revealed rheumatology as the most satisfying of medical specialties. This came as a surprise to many as rheumatologists see themselves as the Rodney Dangerfields of medical specialists.

Letter to the Expert: Is there life after ONJ?

Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?

The Nine Lives of Hydroxychloroquine

The hydroxychloroquine story begins in 1638 when the wife of the Viceroy of Peru, Countess Cinchona, acquired malaria while living in the New World.

Hot Stuff Part IV: Cardiovascular Outcomes and Vasculitis

The last in a four-part series from the CCF's Biologic Therapies Summit, we examine how to reduce CV risks in practice plus the current status of vasulitis management and the role biologics may play.

×